OPKO Health, Inc. Shareholders' Equity
OPKO Health, Inc. (OPK) had Shareholders' Equity of $1.18 billion as of 2026-06-30, per its 10-Q/A filed 2026-08-28.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-28
- 2026-06-30: Stockholders' Equity Attributable to Parent $1.18B.
- 2026-03-31: Stockholders' Equity Attributable to Parent $1.20B.
- 2025-12-31: Stockholders' Equity Attributable to Parent $1.27B.
- 2025-09-30: Stockholders' Equity Attributable to Parent $1.31B.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $1.18B 10-Q/A · filed 2026-08-28 | |
| 2026-03-31 | $1.20B 10-Q/A · filed 2026-08-28 | |
| 2025-12-31 | $1.27B 10-Q/A · filed 2026-08-28 | |
| 2025-09-30 | $1.31B 10-Q · filed 2025-10-29 | |
| 2025-06-30 | $1.30B 10-Q/A · filed 2026-08-28 | |
| 2025-03-31 | $1.31B 10-Q/A · filed 2026-08-28 | |
| 2024-12-31 | $1.37B 10-Q/A · filed 2026-08-28 | |
| 2024-09-30 | $1.40B 10-Q · filed 2025-10-29 | |
| 2024-06-30 | $1.40B 10-Q · filed 2025-10-29 | |
| 2024-03-31 | $1.25B 10-Q · filed 2025-07-31 | |
| 2023-12-31 | $1.39B 10-K · filed 2026-02-26 | |
| 2023-09-30 | $1.44B 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $1.54B 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $1.55B 10-Q · filed 2024-08-07 | |
| 2022-12-31 | $1.56B 10-K · filed 2026-02-26 | |
| 2022-09-30 | $1.63B 10-Q · filed 2023-11-06 | |
| 2022-06-30 | $1.72B 10-Q · filed 2023-11-06 | |
| 2022-03-31 | $1.61B 10-Q · filed 2023-08-03 | |
| 2021-12-31 | $1.69B 10-K · filed 2025-03-03 | |
| 2020-12-31 | $1.67B 10-K · filed 2024-03-01 | |
| 2019-12-31 | $1.61B 10-K · filed 2022-03-01 | |
| 2018-12-31 | $1.79B 10-K · filed 2022-03-01 | |
| 2017-12-31 | $1.84B 10-K · filed 2021-02-18 | |
| 2016-12-31 | $2.05B 10-K · filed 2020-03-02 | |
| 2015-12-31 | $2.00B 10-K/A · filed 2016-03-24 | $1.98B 10-K · filed 2016-02-29 |
| 2015-09-30 | $1.97B 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $834.79M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $819.90M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $842.14M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $893.26M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $917.39M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $835.22M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $876.41M 10-K · filed 2015-02-27 | |
| 2013-09-30 | $870.73M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $314.48M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $320.82M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $179.39M 10-K · filed 2014-03-03 | |
| 2012-09-30 | $146.26M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $151.50M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $154.98M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $160.88M 10-K · filed 2013-03-18 | |
| 2011-09-30 | $102.48M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $111.16M 10-Q · filed 2011-08-08 | |
| 2010-12-31 | $23.05M 10-K · filed 2013-03-18 | |
| 2009-12-31 | $31.60M 10-K · filed 2013-03-18 | |
| 2008-12-31 | $359.00K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |